Zhai Yun Tan

Seattle Dentists, Clinics And A Hospital Partner To Provide Specialty Care For Teeth

麻豆女优 Health News Original

A pilot project involving Swedish Medical Center and the Neighborcare Health network of community clinics offers care for uninsured adults or those on Medicaid.

Shhh! America鈥檚 Most Common Workplace Injury Is Hearing Loss

麻豆女优 Health News Original

According to the Centers for Disease Control and Prevention, hearing loss is the most common work-related injury with approximately 22 million workers exposed annually to hazardous levels of occupational noise. The Department of Labor has issued a challenge to find new ways to turn down the volume.

Screening Positive For Depression Doesn鈥檛 Mean You鈥檒l Get Treatment, Study Finds

麻豆女优 Health News Original

A study in JAMA Internal Medicine suggests that patients known as the 鈥渨orried well鈥 are actually the highest utilizers of mental health care 鈥 and likely to receive antidepressants.

Doctors, Hospitals Prepare For Difficult Talks Surrounding Medical Mistakes

麻豆女优 Health News Original

MedStar Health is among the hospital systems nationwide that are setting up support systems to help doctors talk openly to patients and their families when treatments go awry.

Genetic Insights About Health Risks Limited By Lack Of Diversity, Study Finds

麻豆女优 Health News Original

A study in the New England Journal of Medicine detailed how the diagnoses of risk for a common hereditary heart disease may have been skewed because studies have traditionally had low numbers of black participants.

Surgeon Says Apps May Turn Organ Donation Support Into 鈥楥oncrete Action鈥

麻豆女优 Health News Original

Dr. Thomas Fishbein of the Medstar Georgetown Transplant Institute is optimistic that efforts by hospitals like his, advocacy groups and app makers, such as Tinder, will increase the number of organ donors.

American 鈥楽tem Cell Tourists鈥 Don鈥檛 Have To Travel Abroad, Study Says

麻豆女优 Health News Original

Treatments marketed as everything from anti-aging applications to therapies for degenerative diseases are increasingly available at commercial clinics in the U.S., but their growing numbers raise ethical and regulatory concerns in the scientific community.